These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

109 related articles for article (PubMed ID: 32698651)

  • 1. Subcellular Performance of Nanoparticles in Cancer Therapy.
    Liu CG; Han YH; Kankala RK; Wang SB; Chen AZ
    Int J Nanomedicine; 2020; 15():675-704. PubMed ID: 32103936
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Selective delivery of imaging probes and therapeutics to the endoplasmic reticulum or Golgi apparatus: Current strategies and beyond.
    Cho H; Huh KM; Shim MS; Cho YY; Lee JY; Lee HS; Kwon YJ; Kang HC
    Adv Drug Deliv Rev; 2024 Sep; 212():115386. PubMed ID: 38971180
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cellular organelles as drug carriers for disease treatment.
    Hu J; Liu Y; Du Y; Peng X; Liu Z
    J Control Release; 2023 Nov; 363():114-135. PubMed ID: 37742846
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Molecular Mechanisms of Intracellular Delivery of Nanoparticles Monitored by an Enzyme-Induced Proximity Labeling.
    Ren J; Zhang Z; Geng S; Cheng Y; Han H; Fan Z; Dai W; Zhang H; Wang X; Zhang Q; He B
    Nanomicro Lett; 2024 Feb; 16(1):103. PubMed ID: 38300384
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effective strategies to enhance the diagnosis and treatment of RCC: The application of biocompatible materials.
    Li J; Luo P; Liu S; Fu M; Lin A; Liu Y; He Z; Qiao K; Fang Y; Qu L; Yang K; Wang K; Wang L; Jiang A
    Mater Today Bio; 2024 Aug; 27():101149. PubMed ID: 39100279
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Organelle Targeted Drug Delivery: Key Challenges, Recent Advancements and Therapeutic Implications.
    Singh D
    Endocr Metab Immune Disord Drug Targets; 2024; 24(13):1480-1487. PubMed ID: 38303531
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Organelle-targeting ratiometric fluorescent probes: design principles, detection mechanisms, bio-applications, and challenges.
    Goshisht MK; Tripathi N; Patra GK; Chaskar M
    Chem Sci; 2023 Jun; 14(22):5842-5871. PubMed ID: 37293660
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The Anti-Cancer Effects of Mitochondrial-Targeted Triphenylphosphonium-Resveratrol Conjugate on Breast Cancer Cells.
    Jiang L; Yu H; Wang C; He F; Shi Z; Tu H; Ning N; Duan S; Zhao Y
    Pharmaceuticals (Basel); 2022 Oct; 15(10):. PubMed ID: 36297383
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Sequential Drug Delivery in Targeted Cancer Therapy.
    Yu H; Ning N; Meng X; Chittasupho C; Jiang L; Zhao Y
    Pharmaceutics; 2022 Mar; 14(3):. PubMed ID: 35335949
    [TBL] [Abstract][Full Text] [Related]  

  • 10. 4-Hydroxyl-oxoisoaporphine, one small molecule as theranostic agent for simultaneous fluorescence imaging and photodynamic therapy as type II photosensitizer.
    Xu Q; Ji Y; Chen M; Shao X
    Photochem Photobiol Sci; 2021 Apr; 20(4):501-512. PubMed ID: 33743176
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Targeting tumour-supportive cellular machineries in anticancer drug development.
    Dobbelstein M; Moll U
    Nat Rev Drug Discov; 2014 Mar; 13(3):179-96. PubMed ID: 24577400
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Drug delivery: beyond active tumour targeting.
    Sagnella SM; McCarroll JA; Kavallaris M
    Nanomedicine; 2014 Aug; 10(6):1131-7. PubMed ID: 24823644
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Recent advances in drug delivery systems for enhancing drug penetration into tumors.
    He B; Sui X; Yu B; Wang S; Shen Y; Cong H
    Drug Deliv; 2020 Dec; 27(1):1474-1490. PubMed ID: 33100061
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Nanopreparations for organelle-specific delivery in cancer.
    Biswas S; Torchilin VP
    Adv Drug Deliv Rev; 2014 Feb; 66():26-41. PubMed ID: 24270008
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A novel progress of drug delivery system for organelle targeting in tumour cells.
    He Z; Zhang Y; Khan AR; Ji J; Yu A; Zhai G
    J Drug Target; 2021 Jan; 29(1):12-28. PubMed ID: 32698651
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Organelle targeting: third level of drug targeting.
    Sakhrani NM; Padh H
    Drug Des Devel Ther; 2013; 7():585-99. PubMed ID: 23898223
    [TBL] [Abstract][Full Text] [Related]  

  • 17.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 18.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 19.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.